Achalasia is a condition that can be treated either by surgery, such as Heller myotomy
associated with an antireflux procedure, or by pneumatic dilation, the choice of type of …

BACKGROUND: Achalasia is an uncommon motility disorder of the esophagus with an
uncertain etiology that can go undiagnosed for years. Esophageal manometry and barium …

Though achalasia is a relatively rare disease, with an estimated prevalence of 0.5–1 new
cases per 100,000 population a year, and with no clear age predilection, it is the most …

AIM: Achalasia is a well-known disease among esophageal motility disorders, and all
treatments for this disease are aimed at relaxing the lower esophageal sphincter (LES) …

Abstract Treatment of achalasia includes pneumatic dilation (PD) and surgical myotomy
(SM). Success rates range from 32% to 98% and are mostly based on symptomatic …

Aim: It is recommended that management of complex benign upper gastrointestinal
pathology is discussed at multi disciplinary team (MDT) meetings. American College of …

Background and objectives The most efficient long-term treatment strategy for achalasia has
yet to be established. This study compared the long-term results (≥ 10 years) after either …

Currently, the most effective therapy for achalasia is laparoscopic Heller myotomy with
partial fundoplication. The aim of this study was to compare the long-term results between 2 …

Introduction Achalasia is a rare esophageal disease with potentially lethal complications.
Knowledge of the outcomes of the different surgical treatment modalities for achalasia by …

Heller myotomy in patients with achalasia promises better long-term success than
pneumatic dilation, especially in younger patients, and therefore has evolved as the primary …